MYC Expression and Metabolic Redox Changes in Cancer Cells: A Synergy Able to Induce Chemoresistance

Oxidative Medicine and Cellular Longevity - United States
doi 10.1155/2019/7346492
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Hindawi Limited

Related search

Rab27B-Mediated Metabolic Reprogramming Induces Secretome Acidification and Chemoresistance in Breast Cancer Cells

Exosomes and Microvesicles
2013English

MYC Sensitizes Cancer Cells to Antimitotic Therapies

Cancer Discovery
Oncology
2015English

MONDOA Is Required for MYC-Driven Metabolic Changes

Cancer Discovery
Oncology
2015English

Abnormal Expression of C-Myc Oncogene in NK Cells in Patients With Cancer

International Journal of Molecular Sciences
Organic ChemistryMolecular BiologyTheoretical ChemistryInorganic ChemistryComputer Science ApplicationsSpectroscopyMedicineCatalysisPhysical
2019English

Interferon-Γ Upregulates SOCS3 Expression to Reduce Cisplatin Chemoresistance in Non-Small Cell Lung Cancer A549 Cells

Chemotherapy: Open Access
2016English

miR-492 Promote Chemoresistance to CDDP and Metastasis by Targeting Inhibiting DNMT3B and Induce Stemness in Gastric Cancer

Bioscience Reports
BiochemistryCell BiologyMolecular BiologyBiophysics
2020English

Wedelolactone, an Anti-Inflammatory Botanical, Interrupts C-Myc Oncogenic Signaling and Synergizes With Enzalutamide to Induce Apoptosis in Prostate Cancer Cells

Molecular Cancer Therapeutics
Cancer ResearchOncology
2016English

Hyperglycaemia-Induced Chemoresistance of Prostate Cancer Cells Due to IGFBP2

Endocrine-Related Cancer
Cancer ResearchEndocrinologyOncologyMetabolismDiabetes
2013English

PIN1 Maintains Redox Balance via the C-Myc/Nrf2 Axis to Counteract Kras-Induced Mitochondrial Respiratory Injury in Pancreatic Cancer Cells.

Cancer Research
Cancer ResearchOncology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy